Portfolio company
Noetik
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This biotechnology company develops precision cancer immunotherapies using machine learning and multimodal human tumour data for pharmaceutical partners and clinical applications.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cold Start Therapeutics
This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.
Genevation
This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.
Waypoint Bio
This company develops cell therapies for solid tumours using a spatial biology and machine learning platform to assist patients with difficult-to-treat cancers.
Asylia Diagnostics
This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
ScienceMachine
This company develops autonomous artificial intelligence agents to automate biomedical data analysis and research workflows for biotechnology and pharmaceutical organisations.
Fore Bio
This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
